유방 영상 시장 : 기술별, 최종사용자별 - 세계 예측(2025-2030년)

The Breast Imaging Market was valued at USD 4.88 billion in 2023, expected to reach USD 5.32 billion in 2024, and is projected to grow at a CAGR of 9.10%, to USD 8.99 billion by 2030.

Breast imaging is a crucial component in the diagnostic, preventative, and therapeutic landscape of breast healthcare. It encompasses various imaging techniques such as mammography, ultrasound, MRI, and newer technologies like 3D mammography (tomosynthesis) and molecular breast imaging. The necessity of breast imaging arises from the widespread prevalence of breast cancer, making early and accurate detection crucial for effective treatment. Clinical applications range from routine cancer screenings to the diagnostic evaluation of breast-related symptoms. End-use scope is extensive, serving hospitals, diagnostic centers, breast care clinics, and research institutions. Market growth is significantly influenced by advancements in imaging technology, increasing awareness regarding early cancer detection, and supportive government initiatives for breast health. Opportunities lie in AI integration for enhanced image analysis, personalized screening approaches, and expansion in emerging economies where screening penetration is low. However, challenges persist including high costs of advanced imaging technologies, potential exposure to radiation, and variability in image interpretation. Limitations also arise from disparities in access to advanced diagnostic facilities in rural and underdeveloped regions. Innovation is ripe in developing cost-effective, non-invasive imaging techniques and enhanced AI-driven diagnostic tools that improve accuracy and reduce false positives. Research into personalized medicine and patient-tailored screening protocols holds promise. The breast imaging market is dynamic, reflecting rapid technological advancements yet contending with economic and infrastructural disparities in healthcare delivery. To strategically accommodate the growth potential, stakeholders should focus on collaborations for technological advancements, policy advocacy for cancer screening programs, and investments in R&D for emerging technologies. The market thrives on continuous innovation and effective dissemination of novel imaging solutions. Thus, maintaining an agile and responsive approach to these evolving technologies and market dynamics is crucial for business success in the breast imaging landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Imaging Market

The Breast Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need for early detection of breast cancer
  • Practical advantages and patient convenience associated with digital mammography
  • Proactive initiative by government and healthcare organization to raise awareness
• Market Restraints
  • High cost associated with the modalities
• Market Opportunities
  • Technology advancements and the complimentary products
  • Rising investments in improving breast cancer research and treatment
• Market Challenges
  • Issues related to false positives, over-diagnosis, and over-treatment associated with breast cancer screening

Porter's Five Forces: A Strategic Tool for Navigating the Breast Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Imaging Market

A detailed market share analysis in the Breast Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Imaging Market

A strategic analysis of the Breast Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Imaging Market, highlighting leading vendors and their innovative profiles. These include Aurora Healthcare Us Corp., Canon Inc., CMR Naviscan Corporation, Delphinus Medical Technologies, Inc., EIZO Corporation, Fujifilm Holdings Corporation, General Electric Company, Hologic, Inc., Koninklijke Philips N.V., KUB Technologies, Micrima Limited, Planmed OY by Planmeca OY, Shimadzu Corporation, Siemens AG, and SonoCine, Inc..

Market Segmentation & Coverage

This research report categorizes the Breast Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Ionizing Breast Imaging Technology and Non-Ionizing Breast Imaging Technology. The Ionizing Breast Imaging Technology is further studied across 3D Breast Tomosynthesis, Analog Mammography, Cone Beam Computed Tomography, Full-Field Digital Mammography, Molecular Breast Imaging/Breast-Specific Gamma Imaging, Positron Emission Mammography, and Positron Emission Tomography/Computed Tomography. The Non-Ionizing Breast Imaging Technology is further studied across Automated Whole Breast Ultrasound, Breast MRI, Breast Thermography, Breast Ultrasound, and Optical Imaging.
• Based on End User, market is studied across Breast Care Center, Diagnostic Center, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need for early detection of breast cancer
    • 5.1.1.2. Practical advantages and patient convenience associated with digital mammography
    • 5.1.1.3. Proactive initiative by government and healthcare organization to raise awareness
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the modalities
  • 5.1.3. Opportunities
    • 5.1.3.1. Technology advancements and the complimentary products
    • 5.1.3.2. Rising investments in improving breast cancer research and treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Issues related to false positives, over-diagnosis, and over-treatment associated with breast cancer screening
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Breast Imaging Market, by Technology

• 6.1. Introduction
• 6.2. Ionizing Breast Imaging Technology
  • 6.2.1. 3D Breast Tomosynthesis
  • 6.2.2. Analog Mammography
  • 6.2.3. Cone Beam Computed Tomography
  • 6.2.4. Full-Field Digital Mammography
  • 6.2.5. Molecular Breast Imaging/Breast-Specific Gamma Imaging
  • 6.2.6. Positron Emission Mammography
  • 6.2.7. Positron Emission Tomography/Computed Tomography
• 6.3. Non-Ionizing Breast Imaging Technology
  • 6.3.1. Automated Whole Breast Ultrasound
  • 6.3.2. Breast MRI
  • 6.3.3. Breast Thermography
  • 6.3.4. Breast Ultrasound
  • 6.3.5. Optical Imaging

7. Breast Imaging Market, by End User

• 7.1. Introduction
• 7.2. Breast Care Center
• 7.3. Diagnostic Center
• 7.4. Hospital

8. Americas Breast Imaging Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Breast Imaging Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Breast Imaging Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aurora Healthcare Us Corp.
• 2. Canon Inc.
• 3. CMR Naviscan Corporation
• 4. Delphinus Medical Technologies, Inc.
• 5. EIZO Corporation
• 6. Fujifilm Holdings Corporation
• 7. General Electric Company
• 8. Hologic, Inc.
• 9. Koninklijke Philips N.V.
• 10. KUB Technologies
• 11. Micrima Limited
• 12. Planmed OY by Planmeca OY
• 13. Shimadzu Corporation
• 14. Siemens AG
• 15. SonoCine, Inc.